NYSE:ABC - AmerisourceBergen Stock Price, News, Headlines & Rumors

Sign in or create an account to add this stock to your watchlist.
$85.12 +0.69 (+0.82 %)
(As of 08/15/2018 04:00 PM ET)
Previous Close$84.43
Today's Range$83.01 - $85.15
52-Week Range$71.90 - $106.27
Volume1.38 million shs
Average Volume1.70 million shs
Market Capitalization$17.74 billion
P/E Ratio14.24
Dividend Yield1.83%
Beta1
AmerisourceBergen logoAmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, outsourced compounded sterile preparations, and related services to various healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and other alternate site pharmacies, and other customers. It also provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; and packaging solutions to various institutional and retail healthcare providers. In addition, this segment provides pharmaceutical distribution and other services primarily to physicians who specialize in various disease states, primarily oncology, as well as to other healthcare providers, including hospitals and dialysis clinics; distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and offers third party logistics and outcomes research, and other services for biotechnology and other pharmaceutical manufacturers. The company's Other segment provides commercialization support services, including reimbursement support programs, outcomes research, contract field staffing, patient assistance and co-pay assistance programs, adherence programs, risk mitigation services, and other market access programs to pharmaceutical and biotechnology manufacturers; specialty transportation and logistics services for the biopharmaceutical industry; and animal health care products. It markets its products and services through independent sales forces and marketing organizations. AmerisourceBergen Corporation was founded in 1985 and is headquartered in Chesterbrook, Pennsylvania.

Receive ABC News and Ratings via Email

Sign-up to receive the latest news and ratings for ABC and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NYSE
Industry Drugs, proprietaries, & sundries
Sub-IndustryHealth Care Distributors
SectorMedical
SymbolNYSE:ABC
CUSIP03073E10
Phone610-727-7000

Debt

Debt-to-Equity Ratio1.39
Current Ratio0.94
Quick Ratio0.51

Price-To-Earnings

Trailing P/E Ratio14.24
Forward P/E Ratio13.14
P/E Growth1.28

Sales & Book Value

Annual Sales$153.14 billion
Price / Sales0.12
Cash Flow$8.2721 per share
Price / Cash10.29
Book Value$9.47 per share
Price / Book8.99

Profitability

EPS (Most Recent Fiscal Year)$5.88
Net Income$364.48 million
Net Margins0.69%
Return on Equity48.65%
Return on Assets3.80%

Miscellaneous

Employees20,000
Outstanding Shares216,360,000
Market Cap$17.74 billion

AmerisourceBergen (NYSE:ABC) Frequently Asked Questions

What is AmerisourceBergen's stock symbol?

AmerisourceBergen trades on the New York Stock Exchange (NYSE) under the ticker symbol "ABC."

How often does AmerisourceBergen pay dividends? What is the dividend yield for AmerisourceBergen?

AmerisourceBergen declared a quarterly dividend on Thursday, August 9th. Stockholders of record on Monday, August 20th will be paid a dividend of $0.38 per share on Tuesday, September 4th. This represents a $1.52 dividend on an annualized basis and a dividend yield of 1.79%. The ex-dividend date of this dividend is Friday, August 17th. View AmerisourceBergen's Dividend History.

How were AmerisourceBergen's earnings last quarter?

AmerisourceBergen Corp. (NYSE:ABC) issued its earnings results on Thursday, August, 2nd. The company reported $1.54 EPS for the quarter, beating the Zacks' consensus estimate of $1.46 by $0.08. The business earned $43.14 billion during the quarter, compared to analyst estimates of $43.05 billion. AmerisourceBergen had a return on equity of 48.65% and a net margin of 0.69%. AmerisourceBergen's revenue was up 11.4% on a year-over-year basis. During the same period in the previous year, the firm earned $1.43 earnings per share. View AmerisourceBergen's Earnings History.

When is AmerisourceBergen's next earnings date?

AmerisourceBergen is scheduled to release their next quarterly earnings announcement on Thursday, November, 1st 2018. View Earnings Estimates for AmerisourceBergen.

What price target have analysts set for ABC?

15 brokers have issued 1 year target prices for AmerisourceBergen's stock. Their forecasts range from $88.00 to $115.00. On average, they expect AmerisourceBergen's share price to reach $101.7143 in the next year. This suggests a possible upside of 19.5% from the stock's current price. View Analyst Price Targets for AmerisourceBergen.

What is the consensus analysts' recommendation for AmerisourceBergen?

15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for AmerisourceBergen in the last year. There are currently 6 hold ratings and 9 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for AmerisourceBergen.

Who are some of AmerisourceBergen's key competitors?

Who are AmerisourceBergen's key executives?

AmerisourceBergen's management team includes the folowing people:
  • Mr. Steven H. Collis, Chairman, Pres & CEO (Age 57)
  • Mr. Tim G. Guttman, Exec. VP & CFO (Age 59)
  • Mr. John G. Chou, Exec. VP and Chief Legal & Bus. Officer (Age 62)
  • Dr. Robert P. Mauch, Exec. VP and Group Pres of Pharmaceutical Distribution & Strategic Global Sourcing (Age 51)
  • Mr. James D. Frary, Exec. Officer (Age 46)

Has AmerisourceBergen been receiving favorable news coverage?

News articles about ABC stock have trended somewhat positive this week, Accern Sentiment reports. The research group identifies positive and negative media coverage by reviewing more than twenty million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. AmerisourceBergen earned a news and rumor sentiment score of 0.14 on Accern's scale. They also assigned media stories about the company an impact score of 46.45 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company's share price in the near future. View Recent Headlines for AmerisourceBergen.

Who are AmerisourceBergen's major shareholders?

AmerisourceBergen's stock is owned by a number of of institutional and retail investors. Top institutional investors include BlackRock Inc. (5.81%), Vulcan Value Partners LLC (2.31%), FMR LLC (2.03%), Burgundy Asset Management Ltd. (1.25%), Wells Fargo & Company MN (1.24%) and Beutel Goodman & Co Ltd. (1.04%). Company insiders that own AmerisourceBergen stock include Dale Danilewitz, Gina Clark, Henry Wadsworth Mcgee III, John G Chou, Kathy H Gaddes, Lazarus Krikorian, Peyton R Howell, Richard W Gochnauer, Robert P Mauch, Steven H Collis and Tim G Guttman. View Institutional Ownership Trends for AmerisourceBergen.

Which major investors are selling AmerisourceBergen stock?

ABC stock was sold by a variety of institutional investors in the last quarter, including Westpac Banking Corp, Artisan Partners Limited Partnership, First Quadrant L P CA, Mackay Shields LLC, Janus Henderson Group PLC, Bridgewater Associates LP, BlueMountain Capital Management LLC and Wells Fargo & Company MN. Company insiders that have sold AmerisourceBergen company stock in the last year include Dale Danilewitz, Gina Clark, John G Chou, Kathy H Gaddes, Lazarus Krikorian, Peyton R Howell, Richard W Gochnauer, Robert P Mauch, Steven H Collis and Tim G Guttman. View Insider Buying and Selling for AmerisourceBergen.

Which major investors are buying AmerisourceBergen stock?

ABC stock was bought by a variety of institutional investors in the last quarter, including Fort Washington Investment Advisors Inc. OH, Millennium Management LLC, BlackRock Inc., Unigestion Holding SA, J. L. Bainbridge & Co. Inc., FMR LLC, Beutel Goodman & Co Ltd. and Tavio Capital LLC. View Insider Buying and Selling for AmerisourceBergen.

How do I buy shares of AmerisourceBergen?

Shares of ABC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is AmerisourceBergen's stock price today?

One share of ABC stock can currently be purchased for approximately $85.12.

How big of a company is AmerisourceBergen?

AmerisourceBergen has a market capitalization of $17.74 billion and generates $153.14 billion in revenue each year. The company earns $364.48 million in net income (profit) each year or $5.88 on an earnings per share basis. AmerisourceBergen employs 20,000 workers across the globe.

How can I contact AmerisourceBergen?

AmerisourceBergen's mailing address is 1300 MORRIS DRIVE, CHESTERBROOK PA, 19087. The company can be reached via phone at 610-727-7000 or via email at [email protected]


MarketBeat Community Rating for AmerisourceBergen (NYSE ABC)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  541 (Vote Outperform)
Underperform Votes:  507 (Vote Underperform)
Total Votes:  1,048
MarketBeat's community ratings are surveys of what our community members think about AmerisourceBergen and other stocks. Vote "Outperform" if you believe ABC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ABC will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 8/15/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.